|
Oxford Global Conferences is proud to present Next Generation Sequencing (NGS) Congress, which is to be held on the 16th & 17th November 2009 in Hilton Waldorf, London. The congress is held in conjunction with qPCR Congress (www.qpcr-congress.com).
Next-generation sequencing technologies are revolutionizing biology by allowing for genome-wide transcription factor binding-site profiling, transcriptome sequencing and more recently, whole-genome resequencing. These technologies will provide a genome-wide sequence readout as an endpoint to applications ranging from chromatin immunoprecipitation, mutation mapping and polymorphism discovery to noncoding RNA discovery.
Over the 2 days, the conference provides an overview of the current options of next-generation sequencing platforms, technologies, applications and the newest computational tools for the analysis of next-generation sequencing data.
The event will attract over 120 senior-level decision makers working in bioinformatics & data management, next generation sequencing, discovery, RNA profiling, molecular genomics and clinical & diagnostics development from the UK, Europe and US. This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment.
Who you will meet
Delegates are senior practitioners from major pharmaceutical, biotech companies as well as academics institutions based in UK and Europe and typically include VPs, Directors and Managers of
|
Drug Discovery |
High throughput Technologies |
Bioinformatics |
Data Management |
|
Principal Investigation |
Molecular Profiling/Diagnostics |
Clinical Development |
qPCR |
|
Next Generation Sequencing |
Gene Expression |
Biostatistics |
Genomics |
|
2 Day Conference
